Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease | stella

Learn Data Labs For Researchers Find trials matched to me

Learn Data Labs For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease | stella

Back to Sickle Cell Disease trials

Opening soon

Plain-English translation of NCT07616154 on ClinicalTrials.gov ↗ · Source last updated June 2026 · How we translate trials

Read our Sickle Cell Disease research guide →

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

United States

St Jude Children's Research Hospital, Memphis, Tennessee

Key details

Phase

Testing effectiveness

Sponsor

St. Jude Children's Research Hospital

Enrollment target

~45 participants

Started

September 2026

Primary completion

September 2034

Last updated on clinicaltrials.gov in June 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Akshay Sharma, MD

St. Jude Children's Research Hospital

Interested in joining?

View full record on ClinicalTrials.gov

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.